Single-dose and chronic corticosterone treatment alters c-Fos or FosB immunoreactivity in the rat cerebral cortex by Szakács, Réka et al.
ARTICLE IN PRESSActa histochemica 112 (2010) 147—1600065-1281/$ - s
doi:10.1016/j.
Correspond
E-mail addrwww.elsevier.de/acthisSingle-dose and chronic corticosterone treatment
alters c-Fos or FosB immunoreactivity in the rat
cerebral cortex
Re´ka Szaka´csa, Ildiko´ Fazekasb, Andra´s Miha´lyb,, Bea´ta Krisztin-Pe´vab,
Anna Juha´sza, Zolta´n JankaaaDepartment of Psychiatry, Faculty of Medicine, University of Szeged, Szeged, Hungary
bDepartment of Anatomy, Faculty of Medicine, University of Szeged, PO Box 427, H-6701 Szeged, Hungary
Received 12 July 2008; received in revised form 8 October 2008; accepted 14 October 2008KEYWORDS
Corticosterone;
c-Fos;
FosB;
Immunohisto-
chemistry;
Cerebral cortex;
Ratee front matter & 2008
acthis.2008.10.001
ing author. Tel.: 36 62 5
ess: mihaly@anatomy.sSummary
The aim of this study was to examine the effects of single-dose and chronic
corticosterone treatment on the inducible transcription factor c-Fos and FosB, and
thereby to estimate the effects of high-doses of corticosterone on calcium-
dependent neuronal responses in the rat cerebral cortex. At the same time we
investigated the distribution of interneurons containing calretinin (CR), vasoactive
intestinal polypeptide (VIP) and neuropeptide Y (NPY) in chronically treated animals
in order to collect data on the involvement of inhibitory neurons in this process.
Adult male rats were injected subcutaneously with 10mg corticosterone, whereas
controls received the vehicle (sesame oil). The animals were fixed by transcardial
perfusion 12 and 24 h following single corticosterone injection, and the brains were
processed for c-Fos and FosB immunohistochemistry. To investigate the effects of
repeated corticosterone administration, rats were daily treated with the same
amount of corticosterone (10mg/animal, subcutaneously) for 21 days. Controls were
injected with vehicle. At the end of the experiment, the rats were perfused and
immunohistochemistry was used to detect the presence of the FosB protein, CR, VIP
and NPY. Quantitative evaluation of immunolabelled cells was performed in the
neocortex and the hippocampus. The number of immunoreactive nuclei per unit area
was used as a quantitative measure of the effects of corticosterone. It was found
that a single-dose administration of corticosterone resulted in a significant, time-
dependent increase of c-Fos protein immunoreactivity in the granule cell layer of
the dentate gyrus, as well as in regions CA1 and CA3 of the hippocampus 12 and 24 h
post-injection with respect to control animals. Significant enhancement of c-Fos
immunoreactivity was also observed in the neocortex at 12 and 24 h post-injection.Elsevier GmbH. All rights reserved.
45 665; fax: +36 62 545 707.
zote.u-szeged.hu (A. Miha´ly).
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R. Szaka´cs et al.148Single-dose treatment did not significantly alter FosB immunolabelling. Repeated
administration of corticosterone produced a complex pattern of changes in FosB
immunolabelling: significant increase in FosB immunoreactivity was detected in the
granule cell layer of the dentate gyrus, with no significant changes in the CA1 and
CA3 layers of the hippocampus and in the neocortex. However, a significant decrease
of FosB induction in the neocortex was observed in chronically treated rats in
comparison to single-dose injected animals (12 h before immunohistochemistry).
Analysis of immunohistochemical detection of interneuronal markers revealed a
significant reduction of the CR immunolabelling in the CA3 area of the hippocampus.
No changes in VIP or NPY immunoreactivity were found in the Ammon’s horn 3 weeks
following daily corticosterone treatment. NPY immunoreactivity was significantly
attenuated in the neocortex.
The present data suggest that single-dose corticosterone treatment increases
immunoreactivity of c-Fos protein in a time-dependent manner, 12 and 24 h post-
injection in the rat hippocampus and the neocortex, whereas chronic corticosterone
treatment influences FosB immunoreactivity, primarily in the dentate gyrus. Chronic
corticosterone administration seems to affect CR levels in the CA3 area of the
hippocampus.
& 2008 Elsevier GmbH. All rights reserved.Introduction
Several lines of evidence indicate that glucocor-
ticoids influence activity of brain structures and
that excess glucocorticoid may have deleterious
consequences in the central nervous system, pre-
dominantly in the hippocampus (Sapolsky et al.,
1995; Joe¨ls, 2001). Chronic exposure to excess
glucocorticoid could endanger hippocampal cell
function and morphology, leading to decreased
neurogenesis and increased dendritic atrophy in
the hippocampus and prefrontal cortex, which
might be involved in memory deficits and ensuing
psychopathology (Gould and Tanapat, 1999; Sapolsky,
2000; Wellmann, 2001). Apart from the chronic
effects of glucocorticoids, they may have acute,
short-term neuronal effects, the molecular me-
chanisms of which still remain to be clarified
(Haller et al., 1998). The mechanisms of action of
glucocorticoids in the central nervous system
comprise both genomic and non-genomic effects
(Wolkowitz et al., 2001; Joe¨ls, 2001). Most of the
effects of glucocorticoids are mediated by modula-
tion of gene transcription, through interaction with
corticosteroid receptors: the activated receptors
translocate to the nucleus and affect gene expres-
sion either directly by binding to DNA as homo-
dimers or indirectly, interacting with other
transcription factors (Ayroldi et al., 2002). The
hippocampus is a primary target site for glucocor-
ticoids, the receptors for glucocorticoids being
densely located in the Ammon’s horn, as well as
in the septum and amygdala, regions of the brain
thought to be intimately involved in behavior,
learning and memory function (McEwen et al.,1986; De Kloet, 1991; Wolkowitz et al., 2001). The
prefrontal cortex is similarly a behaviorally rele-
vant target for glucocorticoids since stress alters
prefrontal cortical functions and glucocorticoid
receptors (Rajkowska, 2000; Wolkowitz et al.,
2001).
Corticosterone, the endogenous glucocorticoid of
most rodents, binds to central corticosteroid
receptors, the mineralocorticoid and glucocorticoid
receptors, which are co-expressed in the neurons of
limbic regions, such as the CA1 pyramidal and
dentate granule cells of the hippocampal formation
(Joe¨ls, 2001). Low levels of corticosterone are
sufficient to activate mineralocorticoid receptors
(which are mostly restricted to limbic brain
regions), whereas activation of hippocampal gluco-
corticoid receptors only occurs at high corticoster-
one levels, as seen after stressful events or
following peripheral corticosterone administration
(Reul et al., 1987; Joe¨ls, 2001). Potential targets
for corticosteroid actions that could alter neuronal
membrane properties are the voltage-gated ion
channels (Kerr et al., 1992; Karst et al., 1994) and
neurotransmitter-mediated receptors, including
ligand-gated ion channels and G-protein-coupled
receptors (Joe¨ls, 2001; Czyrak et al., 2002; Wiegert
et al., 2005). Exposure to high levels of corticos-
terone has been reported to increase Ca2+ influx
into hippocampal cells through voltage-gated Ca2+
channels by glucocorticoid receptor activation
(Kerr et al., 1992), resulting in enhanced cell firing
accommodation. However, prolonged exposure
to high concentrations of corticosterone and
glucocorticoid receptor activation may lead to
excessive and uncontrolled Ca2+ influx with
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2001). In addition to the marked sensitivity of the
voltage-gated Ca2+ conductances to corticoster-
oids, high concentrations of the hormone modulate
glutamate and/or GABA-mediated fast synaptic
transmission, including the development of long-
term potentiation (LTP) related to N-methyl-
D-aspartate (NMDA)-receptor-mediated Ca2+ influx
in the CA1 region of the hippocampus within 1 h
(Vidal et al., 1986; Kawato et al., 2001; Shibuya
et al., 2003). High concentrations of corticosterone
administered acutely (within 30min) decrease
NMDA-receptor-mediated Ca2+ elevation in the
CA1 region in hippocampal slices (Sato et al.,
2004). Nevertheless, these rapid modulatory ef-
fects of corticosteroids are not only fast in onset,
but often also reversible within minutes (for a
review, see: Joe¨ls, 2001), revealing the possibility
that corticosteroids may drive, apart from their
genomic effects, acute non-genomic pathways
(Joe¨ls, 2001; Sato et al., 2004).
Members of the activator protein 1 (AP-1) family,
c-Fos and FosB belong to the inducible proto-
oncogenes, which exert various regulatory actions
in the cell nucleus, including late-response gene
transcription that may be critical for neuronal
adaptive responses (Morgan and Curran, 1995;
Herdegen and Leah, 1998; Greenberg and Ziff,
2001). Among the transcription factors encoded by
these immediate early genes (IEGs) are members of
the Fos family of proteins, such as Fos, FosB, Fra-1
and Fra-2, all possessing leucine zippers. These
IEGs are induced by different stimuli, including
membrane depolarisation and Ca2+ influx. Activa-
tion of c-Fos transcription requires Ca2+ influx,
mediated mainly by neurotransmitters acting on
ionotropic receptors, such as NMDA and AMPA types
of glutamate receptors and through voltage-sensi-
tive Ca2+-channels (Greenberg and Ziff, 2001). Fos
immunohistochemistry has widely been used in
neuropharmacological investigations to determine
neuronal activation patterns. Accordingly, previous
studies from our laboratory indicated that immu-
nohistochemical detection of Fos protein serves as
a marker of neuronal activation in forebrain
structures (Miha´ly et al., 2001; Szaka´cs et al.,
2003; Fazekas et al., 2006). In the experiments
reported here, we investigated the changes in c-Fos
and FosB immunolabelling following a single injec-
tion of corticosterone and we tested the alterations
of FosB immunoreactivity after chronic corticoster-
one treatment in order to estimate the effects of
high-doses of corticosterone on calcium-dependent
neuronal responses. Several investigations have
revealed the fundamental role of inhibitory neu-
rons in the control of (calcium-dependent) synapticmechanisms, synaptic plasticity and network activ-
ity in the hippocampus (Acsa´dy et al., 1996; Freund
and Buzsa´ki, 1996). We therefore used immunola-
belling to identify calcium-binding protein, calre-
tinin (CR)-containing interneurons, as well as
interneurons containing neuropeptides, such as
vasoactive intestinal polypeptide (VIP) and neuro-
peptide Y (NPY), which label specific populations of
interneurons.Materials and methods
Animals and treatments
Adult male Wistar rats weighing 200–220 g were
used in the study. The animals were housed in
standard laboratory conditions at constant tem-
perature and humidity, under a 12 h light–dark
cycle. The rats had free access to water and food.
The experiments were conducted in accordance
with prevailing laws and ethical considerations.
Written permission was granted from the Faculty
Ethical Committee on Animal Experiments, Uni-
versity of Szeged.
Corticosterone and sesame oil were purchased
from Sigma-Aldrich (St. Louis, MO, USA). The
corticosterone was suspended in sesame oil at a
volume adjusted to 1ml/kg body weight (b.w.) and
administered by subcutaneous injection (s.c.) into
the nape of the neck. Control animals received the
same amount of the vehicle (sesame oil). Experi-
mental treatments were performed between 7.00
and 10.00 a.m. A total of 44 animals were used. To
study the potential time-dependent, single-dose
and chronic effects of corticosterone, experiments
were performed in separate groups of animals.
Depending on the experiment, treatments were
given either as a single injection of 10mg corticos-
terone, or chronically, as daily injections of 10mg
corticosterone for 21 consecutive days. The dose of
10mg/day was selected consistently with previous
studies showing changes in calcium homeostasis,
including calcium-binding protein regulation in the
hippocampus (Krugers et al., 1994, 1995).
In the part of experiment with single injection of
corticosterone, rats were divided into two groups
of five animals: rats treated with corticosterone
and perfused 12 h after the injection and rats
treated with corticosterone and perfused 24 h
following treatment. The control groups (consisting
of 5 animals each) received only the vehicle
(sesame oil) and were perfused 12 and 24 h
post-injection, respectively. In part of the study
with chronically administered corticosterone, the
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Table 1. Experimental groups, the number of animals and the immunohistochemical procedures performed in
different groups.
Experiments Corticosterone-treated animals
(10mg, s.c.)
Animals treated only with the vehicle
(sesame oil; 1ml/kg)
Duration of treatment Number of rats Immunohistochemistry Number of rats Immunohistochemistry
12 h 5 c-Fos, FosB 5 c-Fos, FosB
24 h 5 c-Fos, FosB 5 c-Fos, FosB
21 days 12 FosB, CR, VIP, NPY 12 FosB, CR, VIP, NPY
Post-injection time following the single injection of corticosterone and/or vehicle, when the animals were perfused.
R. Szaka´cs et al.150experimental group (12 animals) received
10mg/day corticosterone for 21 days, while the
control group of 12 animals received only the
vehicle (sesame oil). Twenty-four hours following
the last injection the animals were perfused.
Details of all groups are summarized in Table 1.
Prior to transcardial perfusion, rats were deeply
anaesthetised with diethyl-ether and perfused with
0.1M phosphate-buffered saline (PBS, pH 7.4),
followed by 4% phosphate-buffered paraformalde-
hyde (pH 7.4) as a fixative. Brains were rapidly
removed from the skull and post-fixed in 4%
paraformaldehyde for 24 h at room temperature,
before being cryoprotected overnight in 30%
sucrose in PBS, pH 7.4. Serial coronal plane sections
were cut at 24 mm thickness using a freezing
microtome (Reichert-Jung, Cryocut 1800), and
every fifth section was processed for immunohis-
tochemistry.Immunohistochemistry
c-Fos immunohistochemistry
Immunohistochemical labelling to localize c-Fos
was performed as described below, using the
streptavidin-peroxidase technique. Free-floating
tissue sections were rinsed in PBS and subsequently
pretreated for 10min with 3% H2O2 and 0.5% Triton
X-100 in PBS to block endogenous peroxidase.
Sections were then rinsed in PBS followed by
incubation for 1 h in 20% v/v normal pig serum
(NPS, Sigma Chemical Co.) to suppress nonpecific
antibody binding to the tissue. Then, brain sections
were incubated overnight at room temperature
with the primary polyclonal antisera against c-Fos
(raised in rabbit; Santa Cruz Biotechnology, CA,
USA) diluted 1: 2000 in 20% v/v NPS, and then in
biotinylated donkey anti-rabbit IgG (Jackson Im-
muno-Research, USA), diluted 1:40 for 1 h. The
secondary antibody was detected by incubating
with streptavidin-peroxidase (Jackson Immuno-Re-search), diluted 1:1000 for 1 h. All dilutions and
rinses between incubations were performed in PBS
(pH 7.4). Finally, the enzyme label peroxidase was
visualized by reaction with 0.05% diaminobenzidine
tetrahydrochloride (DAB) containing 0.01% hydro-
gen peroxide and 0.3% nickel-sulphate (all reagents
from Sigma) yielding a black reaction product. The
sections were mounted on gelatine-coated slides,
dehydrated in a graded ethanol series, cleared in
xylene and coverslipped with Entellan (Fluka).
Immunodetection techniques to localize FosB,
CR, VIP and NPY, respectively, were performed as
described in detail here, the steps being identical
and run simultaneously, with variations as de-
scribed in the following sections.
FosB immunohistochemistry
Immunohistochemistry to detect FosB was per-
formed as described in detail previously, except
that the primary antibody against FosB was raised
in rabbit (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), diluted 1:1000 in 20% v/v NPS, followed
by biotinylated donkey anti-rabbit IgG (Jackson
Immuno-Research, USA) diluted 1:40.
CR immunohistochemistry
Immunohistochemistry to detect CR was per-
formed as described in detail previously, except
that the primary antibody against CR was raised in
goat (Santa Cruz Biotechnology, CA) diluted 1:3000
in 20% v/v NPS containing 0.03% thimerosal (Sigma).
Sections were then incubated in biotinylated
donkey-anti-goat IgG (diluted 1:400 in 10% v/v NPS).
VIP immunohistochemistry
Immunohistochemistry to detect VIP was per-
formed as described in detail previously, except
that the primary antibody against VIP was a
polyclonal raised in rabbit (1:18000 dilution in
20% v/v NPS containing 0.03% thimerosal. The
second layer was biotinylated anti-rabbit IgG raised
in goat (1:400, in 10% v/v NPS).
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Immunohistochemistry to detect NPY was per-
formed as described in detail previously, except
that the primary antibody against NPY was a
polyclonal raised in rabbit (Santa Cruz Biotechnol-
ogy, CA), diluted at 1:50.000 in 20% v/v NPS
containing 0.03% thimerosal and the second layer
was biotinylated donkey anti-rabbit IgG, diluted
1:400.Negative controls
Controls were performed on free-floating sec-
tions. Labelling was performed exactly as described
above, but primary antisera were omitted. No
labelling was observed in these sections.Analysis of the immunohistochemical data
Quantitative analysis was performed on five
sections per animal from each experimental im-
munohistochemical group (see Table 1.), selected
on the basis of identical stereotaxic coordinates
(Paxinos and Watson, 1998). Areas of interest (AOIs)
for immunoreactive cell counts were selected from
the neocortex (CX) (S1Tr region), regions CA1 and
CA3 of the hippocampus, and from the hilum and
granule cell layer of the dentate gyrus (DG). The
AOIs were determined using the rectangular image-
capturing field of the camera. Within each AOI, the
immunolabelled neuronal nuclei were counted
using a Nikon Eclipse 600 microscope equipped
with a SPOT RT Slider digital camera (1600 1200
dpi in 8 bits), using the Image ProPlus 4.0
morphometry software (Media Cybernetics, Silver
Spring, MD, USA). Following background subtrac-
tion, the threshold was adjusted so that all labelled
nuclei could be recognized. The counting was
performed by an investigator blinded to the
treatment group assignment.
In the CX, cell counts were performed using a
10 objective magnification, and the AOI (an area
of 0.2mm2) included each neocortical layer (I–VI),
so that the layers were not evaluated separately.
Then, cell counts were normalised to 1mm2. In the
hippocampus, counting was performed using a 40
objective. In areas CA1-3 of the Ammon’s horn, the
AOI (an area of 0.05mm2) included the Stratum
pyramidale, and a narrow zone of the Strata oriens
and radiatum. The hilum of the DG was outlined
according to Amaral (1978), and used as AOI. The
whole extent of the upper and lower blades of the
granule cell layer was outlined and used as AOI, and
immunolabelled nuclei were counted in this area.
Cell counts were again normalised to 1mm2.The data were analysed statistically comparing
sets of findings obtained with the same magnifica-
tion. ANOVA, followed by the Bonferroni post hoc
test was used to determine differences in the
number of immunoreactive nuclei in the control
and corticosterone-treated animals. Significance
level was Po0.05.Results
Effects of single-dose corticosterone
administration on c-Fos immunoreactivity
c-Fos-immunoreactive cell nuclei were present in
areas CA1-3 of the hippocampus, the granule cell
layer of the DG, as well as in every layer of the CX
12 and 24 h following corticosterone administra-
tion. Most of the labelled nuclei in the Ammon’s
horn were detected in the pyramidal cell layer,
which was strongly immunoreactive, whilst the
Strata oriens, radiatum and lacunosum-moleculare
contained a few, scattered c-Fos immunopositive
nuclei. c-Fos immunopositive cell nuclei were
observed in the granule cell layer of the DG, only
weak c-Fos-immunopositivity was visible in the
hilum. Accordingly, the cell nuclei in the hilum of
the DG were not counted. Numerous, strongly
labelled, activated cells were seen in layers II–VI
of the CX 12 and 24 h following corticosterone
treatment.
c-Fos-immunopositivity was not totally absent
from these regions of the control animals receiving
only the vehicle (sesame oil), since some scattered
c-Fos-immunoreactive nuclei could be detected in
the hippocampus, granule cell layer of the DG and
in the CX.
Twelve hours following corticosterone adminis-
tration, the pyramidal cell layer of the Ammon’s
horn and the dentate granule cell layer apparently
contained more c-Fos immunopositive cell nuclei
compared to control animals, and the number of
immunoreactive nuclei was markedly higher in the
region CA3, as confirmed by statistical evaluation.
Moreover, corticosterone treatment resulted in
significant increase in c-Fos immunopositive cell
nuclei in the CX at 12 h after the injection, and the
number of immunolabelled nuclei subsequently
increased by 24 h. Quantification revealed that
the number of c-Fos immunopositive cell nuclei
significantly increased in CA1 and CA3 regions of
the hippocampus, in the granule cell layer of the
DG, as well as in the CX at 24 h post-injection, with
respect to the control animals. Fos immunoreactiv-
ity in regions CA1 and CA3 of the Ammon’s horn
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Figure 1. Results of c-Fos immunopositive cell counts in the hippocampus (CA1, CA3), in the dentate gyrus (DG) and the
neocortex (CX) in corticosterone-treated rats 12 and 24 h post-injection compared with animals injected only with the
vehicle (sesame oil). High dose of corticosterone significantly increased c-Fos immunopositivity in CA3 at 12 h, and it
resulted in significant increase in c-Fos labelling in CA1, CA3 and DG by 24 h in comparison to controls. Note that
hippocampal c-Fos immunoreactivity increased gradually between 12 and 24 h post-injection. Corticosterone treatment
significantly increased neocortical c-Fos immunoreactivity 12 and 24 h post-injection. Asterisks denote significant
differences (po0.001; ANOVA); the standard errors of the mean (SEM) are displayed as vertical bars.
R. Szaka´cs et al.152increased gradually between 12 and 24 h post-
injection (Figure 1).Effects of single-dose and chronic
corticosterone administration on FosB
immunoreactivity
A low number of FosB immunolabelled cell nuclei
were present in areas CA1-3 of the hippocampus,
whereas the granule cell layer of the DG contained
more numerous FosB immunoreactive nuclei in all
investigated groups. The hilum was regularly
devoid of FosB immunoreactivity by 12 and 24 h,
similar to that observed in c-Fos immunolabelled
samples. Repeated corticosterone treatment did
not induce activation of the hilar cells. The CX
displayed FosB immunolabelling in layers II–VI in
acutely treated animals, with an overall decrease
of labelled cells after chronic corticosterone
administration.
Quantitative analysis revealed that application of
corticosterone did not significantly alter FosBimmonoreactivity in the hippocampus, the granule
cell layer of the DG or the CX 12 or 24 h following
single injection with respect to control animals.
However, repeated administration of corticoster-
one for 21 days resulted in a significant increase of
FosB immunolabelled cell nuclei in the granule cell
layer of the DG. Three weeks of daily corticoster-
one treatment did not induce significant changes in
the number of FosB immunoreactive cells in any of
the hippocampal subfields.
Significant decrease of FosB immunolabelling was
observed in the neocortical layers following chronic
corticosterone administration (most pronounced
decrease in layers II/III) compared to the number
of immunoreactive cell nuclei at 12 h (Figure 2).Effects of chronic corticosterone
administration on CR, VIP and NPY
immunoreactivity
The CR immunoreactive cell bodies were ob-
served mainly in the pyramidal layer of the
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Figure 2. Effects of corticosterone treatment on FosB immunodetection in the hippocampus (CA1, CA3), in the dentate
gyrus (DG) and the neocortex (CX). Rats were exposed to 12 and 24 h of high dose of corticosterone (single-dose), as
well as to 3 weeks of daily corticosterone treatment. Control animals received only with the vehicle (sesame oil).
Single-dose corticosterone administration did not cause any significant change. Chronic corticosterone treatment
resulted in a significant increase in the number of FosB immunolabelled cell nuclei in DG. Asterisks: significant
differences (po0.001; ANOVA); SEM is indicated in every case.
Corticosterone and c-Fos or FosB in the rat cerebral cortex 153hippocampus, although some scattered cells were
found in the inner zone of the Stratum radiatum,
adjacent to the Stratum lacunosum-moleculare. CR
immunopositive perikarya were most abundant in
the Strata pyramidale of the CA1 and CA3 subfields
of the Ammon’s horn, and occasionally they could
be found in the CA2 region, as well. Accordingly, we
did not attempt to investigate the number of CR
immunoreactive cells in the CA2 region separately;
instead, cells were analyzed together in sectors
CA1 and CA2 (CA1-2). The dendrites of the CR-
positive neurons were located mainly in the
Stratum radiatum and lacunosum-moleculare. In
the DG, most of the CR-immunopositive cell bodies
were found in the hilus; fewer, but still numerous
CR-immunopositive neurons were seen in the
granule cell layer. Most of the cells possessed long,
thick, strongly labelled dendrites (Figure 3A). CR-
immunopositive interneurons were also detected in
layers II–VI of the CX.
Investigation of the number of CR-immunola-
belled cells revealed that chronic corticosterone
treatment did not change CR immunolabelling insectors CA1-2 of the Ammon’s horn, in the granule
cell layer and the hilar region of the DG, and in the
CX when compared to control animals (rats
injected with sesame oil). However, 3 weeks of
daily corticosterone treatment (10mg/day, s.c.)
significantly reduced the number of CR immunopo-
sitive cells in the CA3 area of the hippocampus
(Figure 3B).
Following immunolocalisation of VIP, immunopo-
sitive neurons were seen in Strata pyramidale and
lacunosum-moleculare of the Ammon’s horn, most
of the cell bodies being localized in region CA1, and
less frequently in the CA3 area. VIP immunoreac-
tive cell bodies were different in size and shape, as
large multipolar, medium-sized and small oligopo-
lar cells were also detectable. The majority of the
VIP immunoreactive dendrites were long, rarely
branching, with a straight course in the Stratum
radiatum. VIP immunoreactive cells were present
in the granule cell layer and in the hilum of the DG.
A few, scattered cells were seen in the outer
molecular layer (not counted). VIP immunopositive
neurons were also visible in all layers of the CX.
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Figure 3. (A) Appearance of the CR immunolabelling in the DG. The arrow indicates a CR immunoreactive cell body,
while arrowheads point to the dendrites of the cell; s.g.: Stratum granulosum, s.m.: Stratum moleculare. Bar: 100 mm.
(B) Results of CR-immunopositive cell counts in the Ammon’s horn (CA), in the granule layer of the dentate gyrus (GD)
and in the hilum (HILUS), as well as in the neocortex (CX) in corticosterone-treated animals compared with rats injected
with the vehicle. Three weeks of corticosterone treatment decreased the number of CR immunopositive neurons
exclusively in the CA3 region. Significant differences are shown by asterisks (Po0.005). The standard error of the mean
is displayed at the top of the columns.
R. Szaka´cs et al.154Three weeks of treatment with a high dosage of
corticosterone (10mg/day) did not affect the
number of VIP immunoreactive neurons in the
above regions (Figure 4). No changes in VIP
immunolabelling pattern were found in the hippo-
campus, in the DG or in the CX after 3 weeks of
daily corticosterone treatment.
NPY-immunoreactive neurons were located in
Strata pyramidale and oriens of the CA1-3 subfields
of the Ammons’s horn; smaller number of cells was
also present in Stratum radiatum, with higher
frequency close to the granule cell layer. Stratum
lacunosum-moleculare was regularly devoid of NPY
immunopositive cell bodies. Most of the NPY-
containing perikarya were partially labelled, with
different morphological features (large multipolar,
pyramidal shaped and fusiform cell bodies werealso distinguishable). In the DG, the majority of the
NPY-immunoreactive neurons were seen in the
hilum and at the base of the granule cell layer
(bordering the hilum). NPY immunopositive neurons
were present in all layers of the CX. Quantification
revealed that chronic corticosterone treatment did
not alter NPY immunoreactivity in the hippocampus
and the DG. However, a significant reduction of NPY
immunopositive interneurons in the CX was found
after three weeks of daily costicosterone treatment
(Figure 5).Discussion
Our previous results were in accord with data
in the literature concerning the detection and
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Figure 4. VIP immunoreactive neurons in the Ammon’s horn (CA), in the granular layer of the dentate gyrus (GD), in the
hilum (HILUS) and in the neocortex (CX) in rats treated for three weeks with corticosterone (10mg/day, s.c.) and in
control animals (given only the vehicle). Three weeks of treatment with corticosterone did not significantly alter the
number of VIP-immunoreactive neurons.
Figure 5. NPY-immunoreactive neurons in the Ammon’s
horn (CA), in the granular layer of the dentate gyrus
(GD), in the hilum (HILUS) and in the neocortex (CX) in
corticosterone-treated rats in comparison with control
animals. Three weeks of treatment with corticosterone
significantly decreased NPY immunoreactive cell number
in the CX (Po0.005).
Corticosterone and c-Fos or FosB in the rat cerebral cortex 155evaluation of Fos immunoreactivity as a marker
of neuronal activation (Miha´ly et al., 2001;
Szaka´cs et al., 2003; Fazekas et al., 2006).
Expression of c-Fos is induced mainly by transmitter-
mediated input and voltage-dependent Ca2+ currents(Greenberg and Ziff, 2001), and thereby Fos protein
detection is a recognized marker of rapid changes
in neuronal activity, reliable and widely used for
pharmacological investigations (Campeau et al.,
1997; Skorzewska et al., 2006). A brief activation of
glucocorticoid receptors occurring at high corticos-
terone levels leads to enhanced Ca2+ influx into
hippocampal cells, mediated principally by vol-
tage-gated Ca2+ channels (Joels, 2001). There is
evidence that acute administration of high doses of
corticosterone or exposure to various acute stres-
sors affects (among emotional, behavioural and
hormonal responses) Ca2+-mediated neuronal re-
sponses, including immediate-early gene, such as
c-Fos gene, and thereby Fos protein localisation,
within several brain regions with a focus on
subcortical limbic structures (Melia et al., 1994;
Cullinan et al., 1995; Chowdhury et al., 2000;
Skorzewska et al., 2007). In the present study, we
found that acutely administered high-doses of
corticosterone (10mg s.c.) increased c-Fos
immunolabelling in the hippocampus in a time-
dependent manner, as hippocampal c-Fos immu-
noreactivity increased gradually between 12 and
24 h after corticosterone injection, and was highest
at 24 post-injection. This overall increase in the
number of c-Fos-immunopositive cells in the CA1
and CA3 subfields of the hippocampus is consistent
with other studies finding a significant induction of
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hippocampus in response to acute stressors,
although the pattern and the time course of
immediate early gene and protein detection varies
with stimulus type and intensity (Cullinan et al.,
1995; Campeau and Watson, 1997; Chowdhury
et al., 2000; Pace et al., 2005). Acute stress-
induced c-Fos mRNA has been reported to reach
peak levels at 60min and is markedly reduced at
2 h post-stress; however, in some cases, a delayed
and/or prolonged induction was detected, which
may be indicative of secondary neuronal activation
in neocortical and allocortical regions (Cullinan
et al., 1995). Our present experiments might
provide evidence that acute administration of a
high dose of corticosterone (10mg. s.c) can lead to
delayed and/or prolonged Fos expression in the
hippocampal formation (12 and 24 h, respectively),
probably through secondary neuronal activation.
However, this issue should be proved by further
experiments by means of in-situ hybridization or
Northern blotting of specific mRNA. It is noteworthy
that we used different experimental paradigm and
importantly higher dose of corticosterone, as the
dose of 5mg/kg was found in previous studies
to increase plasma corticosterone levels in a
manner similar to the effect of an acute stressor
(Skorzewska et al., 2006). Interestingly, some
studies assessing acute stress-associated Fos ex-
pression in the hippocampal subregions found rapid
c-Fos induction and increased levels of Fos protein
in the CA1-CA2 and CA3 areas, as well as in the
inner blade of the DG, whereas Fos decreased in
the outer blade of the DG (Pace et al., 2005). This
special and unusual pattern of changes, a decrease
in DG Fos following acute (restraint) stress, has
been reported also in other studies (Chowdhury
et al., 2000; Fevurly and Spencer, 2004). Although
we did not count the number of activated cells
separately in the DG subfields, we saw a somewhat
similar pattern of dentate Fos immunodetection
12 h after corticosterone injection. Whereas high
levels of corticosterone resulted in visibly en-
hanced c-Fos immunodetection in the inner blade
of the GD, it resulted in less c-Fos immunopositive
cells in the outer blade. However, the total number
of activated cells was slightly, but not significantly,
higher 12 h post-injection, and subsequently in-
creased at 24 h.
Our results indicate that activation of region CA3
occurs at 12 h after corticosterone injection,
followed by activation of the DG and region CA1,
as well as further activation of region CA3 by 24 h.
The CA3 area therefore preceded DG as relates to
the appearance of c-Fos protein. One explanation
of this observation may be a delayed and probablydivergent and less effective activation of the
entorhinal afferents, compared to the pattern and
time course of cell activation at 1–3 h following
acute stress or other factors enhancing presynaptic
glutamate release (Cullinan et al., 1995; Miha´ly
et al., 2001). There is extensive evidence that
glucocorticoids and stress itself causes glutamate
release in the hippocampus (for a review see:
Sapolsky et al., 1995). When activated, the
glutamatergic perforant pathway projects to the
DG and also to the pyramidal neurons of regions
CA3 and CA1 (Jones, 1993), and also impinges on
inhibitory interneurons of the Ammon’s horn
(Freund and Buzsa´ki, 1996; Gulya´s et al., 1999).
Moreover, the mossy fibers innervate not only the
CA3 principal cells, but also the inhibitory inter-
neurons of the hilus and region CA3 (Acsa´dy et al.,
1998), thus exerting a feed-forward inhibition on
the CA3 pyramidal cells. This complex circuitry
might explain our observation regarding the differ-
ences in c-Fos immunolocalisation in region CA3
with respect to the DG and region CA1 at 12 h post-
injection. At very high corticosteroid levels, there
is supposed to be a direct suppression of excitatory
glutamate-mediated input, suppressing tempora-
rily the transfer of excitatory input through the
hippocampus (Joels, 2001). Such suppression of
excitatory glutamatergic neurotransmission
through entorhinal afferents might consequently
diminish or abolish mossy fiber-driven inhibitory
control over CA3 principal cells, leading to activa-
tion of c-Fos. Further exposure to high corticoster-
one level might disrupt the temporary suppression
of excitatory input, as well as this hypothesized
disinhibition mechanism, resulting in the activation
of the DG and, thereby, in the activation of regions
CA3 and CA1 at 24 h.
Our findings are in accordance with data in the
literature as concerns the appearance of Fos
expression in the CX related to acutely increased
corticosterone levels, such as seen following acute
stress or after acute corticosterone administration.
It is notable that most of these data refer to the
alterations of neuronal activity and associated
immediate early gene c-Fos expression in a well-
defined, short time-course. It was shown, for
example, that exposure to stressful novel experi-
ences led to an increase in c-Fos expression in
primary motor as well as primary somatosensory
cortex after 15–60min of exposure to stress (Pace
et al., 2005). Similarly, a dramatic induction of
c-Fos mRNA was observed in several neocortical
regions in response to acute stress, with peak levels
at 0.5–1 h, markedly reduced at 2 h post-stress
(Cullinan et al., 1995). We found that single
injection of high dose of corticosterone induced a
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the CX (area selected from the somatosensory
region) 12 and 24 h post-injection. This result is
consistent with other studies as concerns c-Fos in
cortical areas 1 day following acute corticosterone
administration; however, enhanced activity was
found in the cingulated cortex (Skorzewska et al.,
2007). In another experiment, acute, mild and
severe stress-induced increase in Fos was detected
in the somatosensory cortex, whereas Fos levels in
the cingulated cortex depended on the severity of
acute stress (Chowdhury et al., 2000). These data
indicate that neocortical and allocortical regions
are sensitive to adaptation to acute stress and/or
enhanced corticosterone levels. The present results
might provide further evidence to a delayed
neuronal activation of the CX in response to acutely
increased corticosterone levels.
When reflecting on the overall low level of FosB
labelling in the hippocampus and the somatosen-
sory cortex 12 and 24 h following a single injection
of high dose of corticosterone, we considered the
possibility that this might be a result of an
important distinction between corticosterone-
mediated inductions of the members of the Fos
gene families, such as c-Fos and FosB. The
discrepancy between the region and time-depen-
dent transcriptional profiles of c-Fos and FosB after
acute corticosterone challenge has recently been
reported, as a widespread and transient reduction
of FosB mRNA was found in the hippocampus 0.8 h
after acute corticosterone injection, whereas
changes in c-Fos levels were restricted to the DG
(Hansson and Fuxe, 2008). In the same experiment,
after 24 h of corticosterone exposure a reduction of
FosB mRNA was again detected in CA1 with trends
toward reduction in other hippocampal regions and
the somatosensory cortex. In our experiments, FosB
levels seem to be unaffected by acute corticoster-
one treatment 12 and 24 h post-injection, not only
in the CA1 and CA3 hippocampal subfields and in
the DG, but also in the somatosensory cortex.
However, a slight, but not significant decrease of
FosB labelling could be observed in the CA1 and CA3
regions and a time-dependent significant reduction
of FosB immunoreactivity in the CX; this observa-
tion is in accordance with the recent results of
Hansson and Fuxe (2008). Overall, discrepancies
among hippocampal and neocortical regions were
observed in the present study in terms of acute
corticosterone-induced changes in Fos family dis-
tributon. While acute corticosterone injection
increased the number of c-Fos-immunoreactive cell
nuclei in the hippocampus and the neocortex at
24 h, it did not significantly affect FosB immunor-
eactivity in the hippocampal subregions and causeda time-dependent reduction of FosB immunpositiv-
ity in the somatosensory cortex. These observations
demonstrate that a single, high dose of corticoster-
one can cause a differential acute alteration of
c-Fos and FosB levels in the hippocampus and the
neocortex, which may reveal special acute plasti-
city changes in these structures.
When investigating the impact of repeated
administration of a high dose of corticosterone on
immediate early gene FosB expression, we found
that prolonged treatment with steroid hormone
enhanced FosB immunoreactivity in the DG, while
FosB immunolocalisation was unaffected in CA1 and
CA3 hippocampal subfields and in the somatosen-
sory cortex. It is noteworthy that neocortical FosB
immunodetection was significantly reduced in
chronically corticosterone-treated rats compared
to a single acute administration (12 h post-injec-
ton). Previous studies have shown that repeated
stressful stimuli increase the expression of the
transcription factor FosB in limbic structures and
associated regions, and interestingly, constitutive
absence of FosB influences stress-related behavior-
al traits, as FosB knockout mice exhibit pronounced
behavioral abnormalities when stress levels are
high (Zhu et al., 2007). Both chronic stress and
chronic administration of corticosterone produce
deficits in cognition and behavior, accompanied by
synaptic plasticity changes in corticolimbic struc-
tures, including alterations in neural function,
chemistry and morphology (Woolley et al., 1990;
Watanabe et al., 1992; Luine et al., 1993; Lyons
et al., 2000; Wellmann, 2001). Accordingly, chronic
administration of a high dose of corticosterone
(s.c. injections of 10mg corticosterone, daily for
3 weeks, similar experimental paradigm as used in
our present experiments) was demonstrated to
reorganize dendritic arborisation in pyramidal
neurons in medial prefrontal cortex, reflecting
functional changes in corticolimbic structures
(Wellmann, 2001). Chronic corticosterone treat-
ment was found to produce a complex pattern of
changes in c-Fos expression, as repeatedly adminis-
tered steroid hormone increased c-Fos immunola-
belling in the CA1 and CA2 areas of the
hippocampus, unaffected in the CA3 region, and
decreased the aversive context-induced c-Fos
production in the DG (Skorzewska et al., 2006).
However, the impact of a chronic, high dose of
corticosterone treatment on immediate early FosB
immunopositivity is first reported in the present
study. Chronic corticosterone treatment (10mg s.c.)
significantly enhanced FosB labelling in the DG, but
not in the CA1 and CA3 subfields of the hippocam-
pus. This finding might be of special interest
given the assumed role of the hippocampus, and
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prolonged plasticity changes. Considering the role
of inhibitory neurons in the control of synaptic
mechanisms in the hippocampus, we assessed the
effects of a prolonged, high dose of corticosterone
on specific populations of interneurons. Three
weeks of corticosterone treatment decreased the
number of CR immunopositive neurons exclusively
in the CA3 region, did not affect VIP immunor-
eactivity and reduced the number of NPY-immuno-
positive neurons in the CX. Chronic treatment with
a high dosage of corticosterone did not change CR
immunoreactivity in the granular layer and the
hilus of the DG when compared to control animals.
These observations concerning the DG closely
resemble previous investigations on the calcium-
binding protein, calbindin, immunoreactivity fol-
lowing chronic corticosterone treatment, using the
same dose of steroid hormone (three weeks daily
10mg s.c.; Krugers et al., 1994, 1995). It is
noteworthy, that in these experiments, 3 weeks
of corticosterone treatment was found to increase
calbindin immunoreactivity in the CA1 pyramidal
layer, with no degenerative changes in CA3 area
(Krugers et al., 1995). In the present experiment,
chronic corticosterone treatment significantly and
selectively attenuated CR immunoreactivity in the
CA3 area. The finding that a high dosage of
corticosterone affected CR immunoreactivity in
the CA3 subfield is in accordance with a previous
observation, by Krugers et al. (1995), that CA3
interneurons degenerate 3 weeks following corti-
costerone treatment (Pavlides et al., 1993). Ac-
cordingly, it has been reported that exposure to 3
weeks of corticosterone treatment or stress in-
duces atrophy of apical dendrites of hippocampal
CA3 pyramidal neurons and affects hippocampal
physiology and LTP in the CA3 area (Woolley et al.,
1990; Pavlides et al., 2002). It was also found that
high dose of corticosterone (10mg/day) reduced CR
mRNA levels in several discrete brain areas (Strauss
et al., 1995), indicating that the impact of
corticosterone on brain CR is related to its
pathological effects, including neuronal energy
depletion or interference with normal glial func-
tions. This might explain our present findings that
high dosage of chronic corticosterone treatment
decreased CR immunoreactivity in the CA3 area,
suggesting the pathological effect of steroid hor-
mone on CR in this vulnerable hippocampal sub-
field. It remains, however, to be determined why
this effect was exclusively seen in the CA3 area and
not in other hippocampal subfields or in the DG.
Despite the co-localization of VIP and the
calcium-binding protein, CR, in a subpopulation of
VIP immunoreactive interneurons in the hippocam-pus (Acsa´dy et al., 1996), we did not find any
change in the number of VIP immunopositive cells
in response to chronic corticosterone treatment.
Interestingly, about 50% of the VIP immunoreactive
cells in CA1 and CA3 were shown to be immunopo-
sitive for CR. It should be noted at the same time,
that interneurons co-localizing CR and VIP repre-
sent about 30% of CR containing cells in the CA1
area, but only approximately 10% in the CA3
subfield (Acsa´dy et al., 1996). This relatively small
proportion of the CR containing neurons in the CA3
area might partially explain the discrepancy be-
tween the effects of corticosterone on CR and VIP
immunoreactivity. However, this issue should be
further elucidated using a double labelling techni-
que. The other reason may be the different impact
of corticosterone on CR- and neuropeptide-contain-
ing interneurons in this hippocampal subfield.
This assumption is supported by the observation
that the number of VIP and NPY-immunoreactive
interneurons was unaffected in CA3 area following
administration of high doses of corticosterone.
Nevertheless, chronic corticosterone treatment
did not alter the number of CR-, VIP- and NPY-
containing interneurons in the granule layer or
hilum of the DG.
In summary, the present immunohistochemical
data indicate that apart from the acute effects of
the steroid hormone, chronic corticosterone treat-
ment (10mg/day) (i) enhanced FosB immunoreac-
tivity in the DG and did not affect the number of
CR-, VIP- and NPY-immunopositive interneurons in
the dentate granule layer and the hilus, and (ii)
high dose of corticosterone appears to affect CR
immunoreactivity in the CA1 area. These observa-
tions might help to supplement literature data over
mechanisms related to special plasticity changes in
the hippocampus induced by exposure to high doses
of corticosterone.Acknowledgements
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